Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia

NCT04150887 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: Cusatuzumab
DRUG: Azacitidine
DRUG: Venetoclax

Sponsor

OncoVerity, Inc.

Collaborators

[object Object]
[object Object]